Innovation Pharmaceuticals Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$880K, a 38.4% increase year-over-year.
  • Innovation Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$2.62M, a 44.5% increase year-over-year.
  • Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.17M, a 55% increase from 2022.
  • Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.04M, a 49.2% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.9M, a 109% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.62M -$880K +$548K +38.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$3.17M -$681K -$744K -1181% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 -$2.42M -$698K +$788K +53% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$3.21M -$361K +$1.51M +80.7% Oct 1, 2022 Dec 31, 2022 10-Q 2023-05-15
Q3 2022 -$4.72M -$1.43M +$628K +30.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $63K +$2.63M Jun 10, 2022 Jun 30, 2022 10-K 2022-09-28
Q1 2022 -$7.98M -$1.49M +$2.47M +62.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$10.5M -$1.87M +$4.3M +69.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-15
Q3 2021 -$14.8M -$2.06M -$883K -75.3% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-15
Q2 2021 -$13.9M -$2.57M -$1.09M -73.5% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$12.8M -$3.96M -$2.97M -298% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$9.82M -$6.17M -$3.55M -135% Oct 1, 2020 Dec 31, 2020 10-Q 2022-05-13
Q3 2020 -$6.27M -$1.17M +$377K +24.3% Jul 1, 2020 Sep 30, 2020 10-Q 2022-05-13
Q2 2020 -$6.65M -$1.48M +$37K +2.44% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-27
Q1 2020 -$6.69M -$995K +$142K +12.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$6.83M -$2.63M +$1.35M +34% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-22
Q3 2019 -$8.18M -$1.55M +$500K +24.4% Jul 1, 2019 Sep 30, 2019 10-Q 2021-02-22
Q2 2019 -$8.68M -$1.52M +$3.35M +68.8% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-14
Q1 2019 -$12M -$1.14M +$1.31M +53.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$13.3M -$3.98M +$539K +11.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$13.9M -$2.05M +$2.48M +54.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$16.4M -$4.86M +$386K +7.36% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-30
Q1 2018 -$16.7M -$2.45M +$1.45M +37.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$18.2M -$4.52M -$1.16M -34.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-10
Q3 2017 -$17M -$4.53M -$1.51M -49.7% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-10
Q2 2017 -$15.5M -$5.25M -$2M -61.8% Apr 1, 2017 Jun 30, 2017 10-K 2017-09-11
Q1 2017 -$13.5M -$3.9M -$194K -5.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$13.3M -$3.36M -$35K -1.05% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$13.3M -$3.03M -$451K -17.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$12.9M -$3.24M -$142K -4.58% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-11
Q1 2016 -$12.7M -$3.71M -$814K -28.1% Jan 1, 2016 Mar 31, 2016 10-K 2017-09-11
Q4 2015 -$11.9M -$3.32M -$569K -20.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-09-11
Q3 2015 -$11.3M -$2.58M +$1.82M +41.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-09-11
Q2 2015 -$13.1M -$3.1M +$239K +7.16% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-13
Q1 2015 -$13.4M -$2.9M -$562K -24.1% Jan 1, 2015 Mar 31, 2015 10-K 2016-09-13
Q4 2014 -$12.8M -$2.75M -$1.16M -72.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-13
Q3 2014 -$11.7M -$4.4M -$3.42M -350% Jul 1, 2014 Sep 30, 2014 10-K 2016-09-13
Q2 2014 -$8.25M -$3.34M -$2.2M -193% Apr 1, 2014 Jun 30, 2014 10-K 2014-09-15
Q1 2014 -$6.05M -$2.33M -$1.47M -169% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$4.58M -$1.6M -$848K -113% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$3.73M -$977K -$508K -108% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$3.23M -$1.14M +$424K +27.1% Apr 1, 2013 Jun 30, 2013 10-K 2014-09-15
Q1 2013 -$3.65M -$867K -$558K -181% Jan 1, 2013 Mar 31, 2013 10-K 2014-09-15
Q4 2012 -$3.09M -$749K +$1.31M +63.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-09-15
Q3 2012 -$4.4M -$469K +$492K +51.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-09-15
Q2 2012 -$4.89M -$1.56M -$293K -23.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-09-15
Q1 2012 -$4.6M -$309K +$1.99M +86.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$6.59M -$2.06M -$723K -54% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$5.87M -$961K +$71.7K +6.94% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$5.94M -$1.27M Apr 1, 2011 Jun 30, 2011 10-Q/A 2014-05-16
Q1 2011 -$2.3M Jan 1, 2011 Mar 31, 2011 10-K 2012-10-12
Q4 2010 -$1.34M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$1.03M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.